After loss-of-function in PTEN and gain-of-function in PI3K suggested a mechanism for upregulation of PI(3,4,5)P3 in cancer, blocking PI3K with Wortmannin [59] or related drugs [60] were considered for treatment of cancers, including breast cancer. The gene discussed is PTEN; the disease is breast carcinoma.